Postoperative thrombotic microangiopathy following radical cystectomy for bladder cancer

Anaesthesia and Intensive Care

Volumn 34, Issue 5, 2006, Pages 672-675

  Tauzin Fin, P ^a   Sesay, M ^a   Ryman, A ^a   Ballanger, P ^a   Combe, C ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

Acute renal failure; Bladder cancer; Cystectomy; Disseminated intravascular coagulation; Plasma exchange

Indexed keywords

FRESH FROZEN PLASMA;

ACUTE KIDNEY FAILURE; AGED; AGED HOSPITAL PATIENT; ARTICLE; BLADDER CANCER; BLEEDING; BLOOD EXAMINATION; BLOOD TRANSFUSION; CASE REPORT; CYSTECTOMY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FOLLOW UP; HEMATURIA; HEMODIALYSIS; HUMAN; HYPOTENSION; PERIOPERATIVE PERIOD; PLASMAPHERESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 33750617169     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0603400515     Document Type: Article

References (22)

1. Neild GH. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura: pathophysiology and treatment. Kidney Int Suppl 1998; 64:S45-49.
2. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int Suppl 1998; 66:SS4-57.
3. Chang J, Shipstone A, Llenado-Lee M. Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries. Am J Hematol 1996; 53:11-17.
4. Robson M, Abbs I. Thrombotic thrombocytopenic purpura following hemicolectomy for colonic carcinoma. Nephrol Dial Transplant 1997; 12:198-199.
5. Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting a thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin Thromb Hemost 1999; 25:217-221.
6. Rocha E, Paramo JA, Montes R, Panizo C. Acute generalized, widespread bleeding. Diagnosis and management. Haematologica 1998; 83:1024-1037.
7. Salloh S, Wang JY, Nguyin NP, Hanrahan LR, Sigounes G. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost 2001; 86:828-833.
8. Levi M, DeJonge E, Van der Poll T. New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Ann Med 2004; 36:41-49.
9. Koh MBC, Hunt BJ. The management of perioperative bleeding. Blood Reviews 2003; 17:179-185.
10. Moake JL. Haemolytic-uraemic syndrome: basic science. Lancet 1994; 343:393-397.
11. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347:589-600.
12. Tsai H-M. Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura. Am J Soc Nephrol 2003; 14:1072-1081.
13. Antman KH, Sharin AT, Mayer RJ, Hargreaves HK, Canellos GP. Microangiopathy hemolytic anemia and cancer: a review. Medicine (Baltimore) 1979; 58:377-384.
14. Muller NJ, Pestalozzi BC. Hemolytic uremic syndrome in prostatic carcinoma. Oncology 1998; 55:174-176.
15. Elliott MA, Nichols WL. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Mayo Clin Proc 2001; 76:1154-1162.
16. Lammle B, Kremer Hovinga JA, Albiero L. Thrombotic thrombocytopenic purpura. J Thromb Haemost 2005; 3:1663-1675.
17. Mori Y, Nada H, Gabazzo EC et al. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity. Transfusion 2002; 42:572-580.
18. George JN. How I treat patient with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Blood 2000; 96:1223-1229.
19. Stegmayr BG, Banga R, Berggren L, Norda P, Rydwell A, Vikersfors T. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med 2003; 31:1875-1877.
20. Ballermann B. Endothelial cell activation. Kidney Int 1998; 53:1810-1826.
21. Bergstein JM, Riley M, Bang NU. Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome. N Engl J Med 1992; 327:755-759.
22. Naito S, Kanamori T, Hisano S, Tanaka K, Momose S, Kamata N. Human renal cell carcinoma: establishment and characterization of two new cell lines. J Urol 1982; 128:1117-1121.